These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9484695)

  • 1. Special feature: psychobiologic perspectives on treatment of personality disorders.
    Soloff P
    J Pers Disord; 1997; 11(4):336-44. PubMed ID: 9484695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Personality factors in depressive disorders: contribution of the psychobiologic model developed by Cloninger].
    Pelissolo A; Corruble E
    Encephale; 2002; 28(4):363-73. PubMed ID: 12232546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitters, temperament and social functioning.
    Bond AJ
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):261-74. PubMed ID: 11532380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and limitations of drug studies in temperament research: biochemical responses as indicators of temperament.
    Netter P
    Philos Trans R Soc Lond B Biol Sci; 2018 Apr; 373(1744):. PubMed ID: 29483349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward an integrative model of the spectrum of mood, behavioral and personality disorders based on fear and anger traits: II. Implications for neurobiology, genetics and psychopharmacological treatment.
    Lara DR; Akiskal HS
    J Affect Disord; 2006 Aug; 94(1-3):89-103. PubMed ID: 16712943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy in personality disorders].
    Wedekind D; Bandelow B; Rüther E
    Fortschr Neurol Psychiatr; 2005 May; 73(5):259-67. PubMed ID: 15880304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurobiology of personality disorders: implications for psychoanalysis.
    Siever LJ; Weinstein LN
    J Am Psychoanal Assoc; 2009 Apr; 57(2):361-98. PubMed ID: 19516057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobiologic function and temperament in subjects with personality disorders.
    Mitropoulou V; Trestman RL; New AS; Flory JD; Silverman JM; Siever LJ
    CNS Spectr; 2003 Oct; 8(10):725-30. PubMed ID: 14712170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.
    Soloff PH
    Bull Menninger Clin; 1998; 62(2):195-214. PubMed ID: 9604516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PerCaDim study: relationship between categorical and dimensional approaches of personality].
    Bricaud M; Calvet B; Viéban F; Prado-Jean A; Clément JP
    Encephale; 2012 Sep; 38(4):288-95. PubMed ID: 22980469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based pharmacotherapy for personality disorders.
    Ripoll LH; Triebwasser J; Siever LJ
    Int J Neuropsychopharmacol; 2011 Oct; 14(9):1257-88. PubMed ID: 21320390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of personality disorders: conceptual framework and clinical strategies.
    Gitlin MJ
    J Clin Psychopharmacol; 1993 Oct; 13(5):343-53. PubMed ID: 8227492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuropsychological evaluation of a case of organic personality disorder due to penetrating brain injury].
    Sanz de la Torre JC; Pérez-Ríos M
    Rev Neurol; 1996 Jun; 24(130):643-9. PubMed ID: 8653607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Special feature: pharmacotherapy in personality disorders.
    Kapfhammer HP; Hippius H
    J Pers Disord; 1998; 12(3):277-88. PubMed ID: 9785268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for personality disorders.
    Hori A
    Psychiatry Clin Neurosci; 1998 Feb; 52(1):13-9. PubMed ID: 9682928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special feature: personality disorders: models for treatment and strategies for treatment development.
    Benjamin LS
    J Pers Disord; 1997; 11(4):307-24. PubMed ID: 9484693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of treatment for personality disorders.
    Paris J
    Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An electrophysiological endophenotype of hypomanic and hyperthymic personality.
    Hensch T; Herold U; Brocke B
    J Affect Disord; 2007 Aug; 101(1-3):13-26. PubMed ID: 17207536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychopharmacologic treatment of personality disorders].
    Quante A; Röpke S; Merkl A; Anghelescu I; Lammers CH
    Fortschr Neurol Psychiatr; 2008 Mar; 76(3):139-48. PubMed ID: 18240112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment of the personality disorders.
    Stein G
    Br J Psychiatry; 1992 Aug; 161():167-84. PubMed ID: 1355689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.